Sintx Technologies price to sales ratio SINT
Market value divided by revenue over the last twelve months, since 2015.
- Today, Nov 2, 2026
- 8.6×
- 10-year median
- 3.0×
- Against its 10-year history
- 65th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 0.2× to 103×
- Peer median
- 0.9×
Sintx Technologies' price to sales ratio is 8.6× as of Nov 2, 2026.
That is above its ten-year median of 3.0×, higher than on 65% of days in the last ten years.
Over that time it ranged from 0.2× in Mar 2024 to 103× in Feb 2021.
The median for 3 medical instruments and supplies stocks of a similar size is 0.9×.
Price to sales ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 8.6× | 5.9× | 11.5× |
| 2025 | 11.3× | 1.2× | 12.6× |
| 2024 | 1.6× | 0.2× | 3.8× |
| 2023 | 0.7× | 0.6× | 5.2× |
| 2022 | 5.2× | 3.2× | 29.5× |
| 2021 | 28.5× | 28.5× | 103× |
| 2020 | 55.0× | 5.5× | 71.5× |
| 2019 | 0.5× | 0.5× | 0.7× |
| 2018 | 0.4× | 0.2× | 0.9× |
| 2017 | 0.8× | 0.5× | 1.1× |
| 2016 | 1.0× | 0.5× | 1.3× |
| 2015 | 0.8× | 0.3× | 1.9× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Sintx Technologies' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| SINTSintx Technologies | 8.6× |
| NEPHNephros | 1.7× |
| APTAlpha Pro Tech | 0.9× |
| KEQUKewaunee Scientific | 0.3× |
| Peer median | 0.9× |
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Sintx Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.